In this study, we examined the effects of SphK2 gene deletion on the development of ALL in a model that is not dependent on forced expression of BCR/ABL1 and demonstrated that genetic deletion of SphK2 also inhibits the development of B lineage ALL independent of BCR/ABL1 expression. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.